Böblingen, April 2026 – The EU-Packaging and Packaging Waste Regulation (PPWR) is changing the regulatory requirements for packaging across Europe. It also redefines the framework conditions for the pharmaceutical industry for the years ahead.
PPWR: New EU Requirements for Packaging in the Context of Wörwag Pharma
What is the PPWR?
With the PPWR, the European Union has established, for the first time, a fully harmonised regulatory framework for packaging and packaging waste across Europe. Its objective is to consistently align the entire lifecycle of packaging – from initial design and material selection to recycling and circularity – with sustainability principles.
As a regulation, the PPWR applies directly in all EU Member States, ensuring that environmental standards are implemented uniformly across borders.
The challenge for the pharmaceutical industry: safety meets sustainability
In the pharmaceutical industry, packaging plays a vital role. It protects highly sensitive active ingredients from moisture, light and oxygen, thereby safeguarding the quality, stability and safety of medicines up to the point of use by patients.
The challenge posed by the PPWR lies in reconciling these high safety standards with new environmental requirements. Complex multi-layer materials, such as blister packaging, must be further developed to preserve medical integrity while at the same time meeting strict criteria for recyclability.
Our approach: combining responsibility and innovation
For Wörwag Pharma, the PPWR means considering sustainability and patient safety as an integrated whole. The aim is to further develop packaging solutions in a way that aligns environmental requirements with pharmaceutical quality standards. A key question in this context is how material use and recyclability can be improved without compromising product safety.
This perspective shapes how the company approaches regulatory change in the field of packaging.
Outlook
The PPWR will have a lasting impact on the European packaging landscape in the years to come. For Wörwag Pharma, it represents another building block on the path towards a more responsible use of resources – always with a clear focus on high quality and safety standards for patients.